Lifestyle changes such as nutrition and exercise should be integrated alongside conventional cancer treatments to improve outcomes and mitigate toxicities.

“It doesn't mean that eating healthy and exercise can replace these treatments. It means we march it right alongside treatments to mitigate the toxicities, to improve your vitality during treatment, and then to enhance the treatment outcome for cure after.”

Current standard cancer treatments are often ineffective and toxic, and outcomes could be improved by incorporating metabolic therapy.

“We have drugs that are extremely expensive based on a somatic mutation theory of cancer that are basically not dropping the death rate.”

Exercise is a vital component of cancer treatment that helps patients tolerate therapies better, preserve muscle mass, and improve their prognosis.

“Well, science doesn't support this absolute rest. We already know that people who exercise, especially with a disease like cancer, will feel better, experience less fatigue, and protect their muscle mass.”

Exercise serves as a therapeutic intervention during cancer treatment that can improve therapy completion rates, manage side effects, and potentially enhance survival outcomes.

“some of these Studies have actually shown that it's the patients who exercise during chemotherapy that end up completing more of their chemotherapy they have fewer reductions in the chemotherapeutic drugs and fewer delays and that portends a better outcome a higher chance at cure and a lower risk of”

The mortality rate for cancer has not improved significantly over the last several decades despite substantial financial investment.

“if you want to measure the success of treatment in cancer then the thing you need to look at peter is what is the age adjusted mortality of cancer today in 2020 you know what it is it is the same as it was in 1930.”

The oncology industry is heavily influenced by financial incentives that compromise the medical care provided to patients.

“that was my Tipping Point when I realized that the incestuous relationship between Pharma and um the oncology Community the healers had been so corrupted by their money that everything had fallen off the cliff”

The current cancer research landscape produces many marginal drugs that provide limited survival benefits, failing to meet the standards of truly transformative outcomes.

“if you look at 71 consecutively approved drugs for the solid cancers as fojo and colleagues did in a famous paper a few years ago the average improvement was 2.1 months”